Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 101
Filter
3.
Med Leg J ; 92(1): 2-4, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38334724
5.
Med Leg J ; 91(3): 114-117, 2023 09.
Article in English | MEDLINE | ID: mdl-37309818
6.
Med Leg J ; 91(2): 59-61, 2023 06.
Article in English | MEDLINE | ID: mdl-37017404
7.
Med Leg J ; : 258172221148002, 2023 Apr 06.
Article in English | MEDLINE | ID: mdl-37021515
9.
Med Leg J ; 90(3): 115-116, 2022 09.
Article in English | MEDLINE | ID: mdl-35730332
10.
Med Leg J ; 89(3): 153-154, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34545758
11.
Med Leg J ; 89(2): 71-72, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34152890
13.
Med Leg J ; 89(2): 67-70, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33615885

ABSTRACT

The Covid-19 pandemic in the UK has been greatly worsened by the mutation of the virus, which began in the South East and was rapidly spreading and in danger of overwhelming the NHS as hospital admissions and deaths continued to rise. In consequence, the Chief Medical Officers of all four nations supported the UK government's sudden decision to delay the second dose of the Pfizer/BioNtech and Oxford/AstraZeneka vaccines for 12 weeks (instead of 3) so that more people in the most vulnerable population groups would receive a first dose and some immunity sooner. The expectation is that this strategy would reduce hospital admissions and deaths. This article considers key medical and legal issues arising from this decision and discusses inter alia rationing of scarce resources, fairness, whether it is for the greater good, consent, individual human rights, negligence and claims for potential or actual injury.


Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Decision Making , Government Programs/standards , Jurisprudence , COVID-19/epidemiology , Government Programs/methods , Government Programs/trends , Humans , United Kingdom/epidemiology , COVID-19 Drug Treatment
14.
Med Leg J ; 88(1_suppl): 3-4, 2020 11.
Article in English | MEDLINE | ID: mdl-33054654
16.
Med Leg J ; 88(2): 57-64, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32515258

ABSTRACT

This is a personal view from London as the Covid-19 pandemic continues to spread here and the situation changes from day to day. As such it can only be a snapshot caught in time; it is not a diary of events. The Coronavirus Act 2020 gives Government enormous powers and was passed by Parliament in one day of debate immediately before it closed early for the Easter break. In March, the government imposed a "lockdown: the closure of all" but "essential" businesses and people other than essential workers must work from home but are allowed out for exercise and food shopping but must maintain 2 m apart, the "social distancing rule". The aim is to suppress the spread of the virus, reduce the death toll and "protect the National Health Service (NHS)" which needed time to empty wards and expand its intensive care unit (ICU) capability to deal with an expected influx of thousands of very sick patients. I discuss whether this strategy is working, how and why it has rapidly been altered to respond to criticism. Why was the Government so slow to seek the help of private laboratories to assist with testing? Why was the personal protective equipment (PPE) guidance altered only after criticism? I look at the impact of the lockdown on the UK economy, the changes to practice of medicine and speeding of scientific research. Cooperating with the lockdown has its price; is it harming the health and mental health of children, people living in households with potentially abusive partners or parents and those who are disabled or financially desperate? Is the cure worse than the disease? The Economy is being devastated by the lockdown and each day of lockdown it is worse. Is litigation being seeded even now by the pandemic? Notwithstanding unprecedented Government financial help many businesses are on the edge of collapse, people will lose their jobs and pensioners income. The winners include pharmacies, supermarkets, online food retailers, Amazon, online apps, providers of video games, services, streaming and scientific research laboratories, manufacturers of testing kits, ventilators, hand sanitisers, coffins, undertakers, etc. The British public is cooperating with lockdown but are we less productive at home? Parents with babies and children often child minders, school, grandparents or paid help which is not now available. Will current reliance on video-conferencing and video calls permanently change the way we work and will we need smaller city offices? Will we travel less? Will medical and legal practice and civil and criminal trials be generally carried out remotely? Will social distancing with self-isolation and job losses and business failures fuel depression? Is Covid-19 comparable to past epidemics like the Plague and Spanish flu?


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Anxiety/epidemiology , COVID-19 , Commerce/legislation & jurisprudence , Communicable Disease Control , Coronavirus Infections/transmission , Criminal Law , Depression/epidemiology , Economics , Forecasting , Freedom , Government Regulation , Housing/economics , Humans , Internet , London/epidemiology , Medical Staff, Hospital/supply & distribution , Nursing Staff, Hospital/supply & distribution , Pandemics , Panic , Personal Autonomy , Pneumonia, Viral/transmission , Public Health Administration , Quarantine , SARS-CoV-2 , Schools , Social Control Policies , Social Isolation , Telemedicine , Travel , Triage
19.
Med Leg J ; 87(3): 105-106, 2019 09.
Article in English | MEDLINE | ID: mdl-31507247
SELECTION OF CITATIONS
SEARCH DETAIL
...